Severe Obesity Tied to Breathing Risk in Heart Failure
Among U.S. hospitalized adults with HFpEF and kidney disease, severe obesity was linked to higher odds of respiratory complications.
Updated on Nov. 3, 2026 in Heart Disease

Among hospitalized U.S. adults with heart failure with preserved ejection fraction (HFpEF), severe obesity was linked to higher odds of acute respiratory failure and mechanical ventilation across several stages of chronic kidney disease. The findings come from a large analysis of hospitalizations covering 2016 to 2020 and were published in 2026.
Why it matters
Heart failure with preserved ejection fraction is common in people with obesity and kidney disease, and this study suggests that the combination may raise the risk of serious breathing complications during a hospital stay. The analysis points clinicians toward closer respiratory monitoring for this group, though it cannot confirm that obesity itself causes these outcomes.
This retrospective cohort study analyzed 1,182,104 hospitalizations of adults with HFpEF from the National Inpatient Sample between 2016 and 2020. Class III obesity was associated with higher adjusted odds of acute respiratory failure across CKD Stages 1 through 4, but the analysis could not establish causality.
The players
Am J Heart Plus
A cardiology journal that publishes peer-reviewed research on heart disease, including heart failure and its clinical management.
National Inpatient Sample
A large U.S. hospital discharge database maintained by the Agency for Healthcare Research and Quality, widely used to study hospital care and outcomes.
The details
The researchers ran multivariable logistic regression separately within each stage of chronic kidney disease, using hospitalizations without a coded BMI of at least 25 kg/m² as the reference group. Class III obesity was the only obesity category consistently tied to both primary respiratory outcomes, acute respiratory failure and endotracheal intubation or mechanical ventilation. Increased odds of intubation or ventilation appeared at CKD Stage 2 and persisted through Stage 4. Hospitalizations involving underweight, malnutrition, cachexia, end-stage renal disease or dialysis, metastatic malignancy, active chemotherapy, advanced liver disease, and amyloidosis were excluded from the analysis.
Timeline
Data from 2016 to 2020 were analyzed in the study.
The study was published in 2026 in Am J Heart Plus.
Health Landscape
Heart failure with preserved ejection fraction is a condition in which the heart pumps normally but stiffens, and it is increasingly seen alongside obesity and chronic kidney disease. This analysis uses large-scale U.S. hospital records to map where respiratory complications concentrate within that overlapping patient population.
If you have heart failure, obesity, or chronic kidney disease, this study suggests that breathing complications during hospitalization are worth discussing with your care team. Asking your doctor how your kidney function and weight management fit into your overall heart care is a practical step to take.
The takeaway
Severe obesity appears to be a consistent marker of higher respiratory risk in hospitalized heart failure patients with kidney disease. Bring your weight, kidney function, and breathing concerns into conversations with your physician so they can be monitored together.
Further reading
For more background on the condition at the center of this research, explore our coverage of Heart Disease.
Source note: This article includes information reported by European Medical Journal.





